Fintel reports that on April 3, 2025, Evercore ISI Group downgraded their outlook for Sensata Technologies Holding (NYSE:ST) ...

ChargePoint (NYSE:CHPT – Get Free Report) was downgraded by Evercore ISI from an “outperform” rating to an “in-line” rating ...

That conflict is sure to deepen after Monday's decision by a French court found nationalist Marine Le Pen guilty of embezzlement and barred her from politics for five years, making it unlikely she can ...

Institutional investors and professional traders rely on The Fly to keep up-to-the-second on breaking news in the electric vehicle and clean ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...

Fintel reports that on March 31, 2025, Evercore ISI Group downgraded their outlook for ChargePoint Holdings (NYSE:CHPT) from ...

Evercore ISI analyst Chris McNally downgraded ChargePoint (CHPT) to In Line from Outperform with a price target of $1, down from $4, following ...

Evercore ISI’s price objective points to a potential upside of 6.99% from the company’s previous close. Several other equities analysts have also recently weighed in on RGEN.

Fintel reports that on March 18, 2025, Evercore ISI Group initiated coverage of West Pharmaceutical Services (LSE:0ADY) with a Outperform recommendation. There are 1,494 funds or institutions ...

Microsoft Corp. shares have fallen recently along with other once-hot technology stocks in an unraveling of the artificial-intelligence trade — but Evercore ISI analysts aren’t sure that ...

In addition to Evercore ISI, Vertiv Holdings also received a Buy from Bank of America Securities’s Andrew Obin in a report issued on March 11. However, on March 3, Barclays maintained a Hold ...

On Wednesday, Evercore ISI began coverage on Summit Therapeutics plc (NASDAQ:SMMT) shares, assigning an Outperform rating and setting a price target of $30.00. The $13.65 billion market cap company, ...